Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?

• click to rate

  Posted by Two Blokes Jul 11 - Filed in Stock - 10 views
  
  MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.